Research News
View articles by month and year
-
Chemo During Pregnancy Doesn’t Harm Baby
New research supports other studies that suggest that chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Pathologic Complete Response to Treatment Before Surgery Linked to Better Prognosis
Research found that women who got neoadjuvant treatment and had a complete pathologic response were less likely to have the cancer come back compared to women who didn't have a complete pathologic response.
-
Taxotere Better Than Fluorouracil in Chemo Regimen After Surgery for Early-Stage Disease
Chemotherapy that included Taxotere offered slightly better results than a regimen that included 5-FU for women diagnosed with early-stage breast cancer that hadn't spread to the lymph nodes, but Taxotere was more likely to cause serious side effects.
-
Halaven Approved by FDA to Treat Metastatic Breast Cancer
The FDA has approved a new chemotherapy medicine, Halaven (chemical name: eribulin), to treat metastatic breast cancer that already has been treated with other chemotherapy medicines.
-
Experimental Eribulin May Help Treat Various Types of Metastatic Breast Cancer
Research suggests that the experimental medicine eribulin may be a good treatment for various types of metastatic breast cancer that have stopped responding or failed to respond to other treatments.
-
Chemotherapy Before Surgery Can Benefit Advanced-Stage, Triple-Negative Breast Cancer
A small, early study found that 66% of locally-advanced, triple-negative breast cancers treated before surgery with a combination of carboplatin and Taxotere had no living cancer cells in the tumor when it was removed.
-
Old Women More Likely to Have Chemo-Related Cognitive Problems
Being older and having lower cognitive reserve levels may increase the risk of cognitive problems during and after chemotherapy.
-
New Technique May Find Heart Damage Earlier
Research suggests that a new way to measure heart damage caused by certain breast cancer treatments may find damage earlier than traditional measurement tests.
-
Eribulin May Be Treatment Option for Metastatic Breast Cancer
Research suggests that eribulin, an experimental chemotherapy medicine, may be a good treatment option for metastatic breast cancer that has stopped responding to other treatments.
-
Giving Chemo Medicines Sequentially May Have Advantages
Treating early-stage breast cancer with two chemotherapy medicines followed by a third seems to have some advantages compared to giving two or three medicines at the same time, but may cause more severe side effects.
